Outcome | Women, no (%) | Men, no (%) | Unadjusted OR (95% CI) | Odds ratio adjusted for age,* OR (95% CI) | Odds ratio adjusted for age and other baseline variables,† OR (95% CI) |
Primary outcomes | |||||
Death | 1431 (12.6) | 1967 (6.3) | 2.15 (2.00 to 2.31) | 1.54 (1.43 to 1.66) | 1.50 (1.38 to 1.62) |
Reinfarction | |||||
Fatal | 167 (1.5) | 245 (0.8) | 1.89 (1.55 to 2.30) | 1.44 (1.17 to 1.76) | 1.42 (1.15 to 1.74) |
Non-fatal | 151 (1.3) | 429 (1.4) | 0.97 (0.80 to 1.17) | 0.95 (0.78 to 1.15) | 0.95 (0.78 to 1.15) |
All | 318 (2.8) | 674 (2.2) | 1.31 (1.14 to 1.50) | 1.15 (1.00 to 1.32) | 1.14 (0.99 to 1.32) |
Stroke | |||||
Fatal | 89 (0.8) | 103 (0.3) | 2.39 (1.80 to 3.18) | 1.84 (1.37 to 2.48) | 1.70 (1.26 to 2.29) |
Non-fatal | 77 (0.7) | 176 (0.6) | 1.21 (0.92 to 1.58) | 0.96 (0.73 to 1.27) | 0.90 (0.68 to 1.18) |
All | 166 (1.5) | 279 (0.9) | 1.65 (1.36 to 2.00) | 1.30 (1.06 to 1.58) | 1.20 (0.98 to 1.46) |
Death, reinfarction or stroke | 1655 (14.6) | 2567 (8.2) | 1.91 (1.78 to 2.04) | 1.42 (1.33 to 1.52) | 1.38 (1.28 to 1.48) |
Other outcomes (fatal and non-fatal) | |||||
Cardiogenic shock | 721 (6.3) | 1196 (3.8) | 1.70 (1.55 to 1.87) | 1.29 (1.17 to 1.42) | 1.27 (1.15 to 1.41) |
Heart failure requiring treatment | 1904 (16.7) | 3896 (12.4) | 1.41 (1.33 to 1.50) | 1.09 (1.03 to 1.16) | 1.05 (0.98 to 1.12) |
Cardiac rupture | 207 (1.8) | 218 (0.7) | 2.64 (2.18 to 3.20) | 1.95 (1.60 to 2.37) | 1.94 (1.59 to 2.37) |
Ventricular fibrillation | 412 (3.6) | 805 (2.6) | 1.42 (1.26 to 1.61) | 1.16 (1.02 to 1.31) | 1.12 (0.99 to 1.28) |
Major non-cerebral bleeding | 39 (0.3) | 104 (0.3) | 1.03 (0.71 to 1.49) | 0.77 (0.53 to 1.12) | 0.75 (0.51 to 1.10) |
* Adjusted for age as a continuous covariate, including linear quadratic and cubic terms.
† Adjusted for all baseline characteristics, including previous disease and drug use before hospitalization (table 1).